ShareholdingJun 30, 2026, 06:07 AM
Lakefront Biotherapeutics: Madison Avenue Partners Crosses 5% Stake
AI Summary
Lakefront Biotherapeutics received a transparency notification from Madison Avenue Partners. The notification indicates that Madison Avenue Partners, jointly with its affiliates, crossed above the 5% voting rights threshold on June 15, 2026. As of June 24, 2026, Madison Avenue Partners holds 3,498,892 voting rights, representing 5.31% of Lakefront's total outstanding shares.
Key Highlights
- Madison Avenue Partners crossed the 5% voting rights threshold.
- They now hold 3,498,892 voting rights in Lakefront Biotherapeutics.
- This represents 5.31% of Lakefront's currently outstanding shares.
- The threshold was crossed on June 15, 2026.
- Lakefront Biotherapeutics has 65,897,071 outstanding shares.
Price Impact
More from GLPG